Adamis Pharmaceuticals Corporation Gains 26.96%

Mon, Jan 10, 2022 at 05:30 PM
Adamis Pharmaceuticals Corporation Gains 26.96%

Adamis Pharmaceuticals Corporation (ADMP:NASDAQ) soared at $0.73, representing a gain of 27%. On Fri, Jan 07, 2022, ADMP:NASDAQ hit a New 2-Week Intraday Low of $0.56. The stock got featured on our News Catalysts scanner on Mon, Jan 10, 2022 at 07:39 AM in the 'BIOTECH' category. From Mon, Dec 27, 2021, the stock recorded 44.44% Up Days and 50.00% Green Days

The stock spiked on Mon, Oct 18, 2021 at $1.48 with a volume of 151M+, and its share price has been moving sideways in recent weeks.

About Adamis Pharmaceuticals Corporation (ADMP:NASDAQ)

Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops & commercializes products in the therapeutic areas of respiratory disease & allergy. Its products include Epinephrine Injection PFS syringe, APC-1000, APC-2000, & APC-5000.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.